Opko Health Inc. (OPK) is a publicly traded Healthcare sector company. As of October 25, 2026, OPK trades at $1.62 with a market cap of $1.22B and a P/E ratio of -16.28. OPK moved +1.23% today. Year to date, OPK is +28.35%; over the trailing twelve months it is +7.24%. Its 52-week range spans $0.98 to $2.04. Analyst consensus is strong buy with an average price target of $3.08. Rallies surfaces OPK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Labcorp to buy BioReference assets for $722 million plus 4Kscore earnout: Labcorp will buy select BioReference Health assets from OPKO for $722 million in cash, with up to $150 million more tied to 4Kscore revenue. The businesses are expected to generate about $250 million in revenue in their first year after closing; OPKO says the sale will sharpen its focus on biopharmaceuticals.
| Metric | Value |
|---|---|
| Price | $1.62 |
| Market Cap | $1.22B |
| P/E Ratio | -16.28 |
| EPS | $-0.09 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.04 |
| 52-Week Low | $0.98 |
| Volume | 1.40M |
| Avg Volume | 0 |
| Revenue (TTM) | $587.90M |
| Net Income | $-72.89M |
| Gross Margin | 40.77% |
3 analysts cover OPK: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $3.08.